CPE News – pcJournal (6/25/2018) – Stanley Brothers Holdings Inc. has filed a preliminary prospectus in connection with a proposed initial public offering (IPO) of its common shares by way of a treasury offering and a secondary offering by certain shareholders. The secondary offering will only be conducted as part of an over-allotment exercise.
Canaccord Genuity Corp. is acting as sole bookrunner and sole lead for the offering. DLA Piper (Canada) LLP and Stikeman Elliott LLP act as legal counsel to Stanley Brothers and the agent respectively.
Stanley Brothers Holdings has applied to list the common shares on the Canadian Securities Exchange (CSE).
Stanley Brothers Holdings Inc. is a BC company formed in May 2018 to acquire and hold all of the capital stock in Stanley Brothers, Inc., a Boulder, Colorado based producer and distributor of hemp-based, CBD wellness products.
photo credit: Stanley Brothers
STANLEY BROTHERS HOLDINGS INC. FILES PRELIMINARY PROSPECTUS FOR INITIAL PUBLIC OFFERING OF COMMON SHARES
NOT FOR DISTRIBUTION IN THE UNITED STATES
BOULDER, COLORADO, June 25, 2018 — Stanley Brothers Holdings Inc. (“Stanley Brothers”) today announced that it has filed a preliminary prospectus with the securities regulatory authorities in each of the provinces of Canada, except Quebec, for a proposed initial public offering of its common shares (the “Offering”). The Offering will include a treasury offering by Stanley Brothers and a secondary offering of common shares of Stanley Brothers by certain shareholders. The secondary offering will only be conducted as part of an over-allotment exercise. The number of common shares to be sold and the price per common share have not yet been determined.
Canaccord Genuity Corp. is acting as sole bookrunner and sole lead for the Offering. The preliminary prospectus contains important information relating to the common shares and is still subject to completion or amendment. Copies of the preliminary prospectus are available on SEDAR at www.sedar.com. There will not be any sale or any acceptance of an offer to buy the common shares until a receipt for the final prospectus has been issued.
No securities regulatory authority has either approved or disapproved of the contents of this news release. The common shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws. Accordingly, the common shares may not be offered or sold within the United States unless registered under the U.S. Securities Act and applicable state securities laws or pursuant to exemptions from the registration requirements of the U.S. Securities Act and applicable state securities laws. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities of Stanley Brothers in any jurisdiction in which such offer, solicitation or sale would be unlawful.
ABOUT STANLEY BROTHERS
Stanley Brothers is a market leader in the production and distribution of innovative hemp-based cannabidiol (“CBD”) wellness products. Stanley Brothers’ products are made from high quality and proprietary strains of whole-plant hemp extracts containing a full spectrum of phytocannabinoids, including CBD, terpenes, flavonoids and other minor but valuable hemp compounds. Stanley Brothers’ hemp products have no psychoactive effects, and its current product categories include tinctures (liquid product), capsules and topical products.
For further information, contact:
Cory Pala – Cory.Pala@evestor.com – (416) 657-2400
Rich Mohr – RichM@cwhemp.com – (720) 487-9508